- Johnson & Johnson pays $230m to settle New York opioids case (theguardian.com)
Johnson & Johnson has reached a $230m agreement to settle an opioid lawsuit brought by the attorney general of New York state...“Johnson & Johnson helped fuel this fire, but today they’re committing to leaving the opioid business – not only in New York, but across the entire country...READ MORE
- How Online Drug Dealers Exploit Social Media Algorithms (nabp.pharmacy)
The convenience of internet shopping attracts many young buyers to turn to social media and internet platforms, not only to buy ordinary goods but also medications...What some fail to recognize – especially young adults – is that is that most social media platforms are designed to keep users engaged by pushing content they believe the individual wants based on their activity on the platform..after multiple clicks or searches, the line between what a user was searching for and what content the algorithm is pushing can quickly become blurred...social media algorithms have become so efficient at suggesting content to users, even passive ones, that they have created a perfect pathway for digital drug dealers to connect to potential victims in a matter of a few clicks...READ MORE
- With less demand for surgical relief during pandemic, Sun cuts poppy production in Tasmania (fiercepharma.com)
For many, the sedative power of poppies was introduced by Dorothy in the Wizard of Oz, galloping through flowers before falling fast asleep...Those blooms now provide raw materials for opioid painkillers used by the millions worldwide. But like the Wicked Witch of the West, who cast that poppy spell on Dorothy, the coronavirus pandemic has put a sleeper hold on the production of poppies for pharmaceutical use...The global demand for opium-based products plummeted last year as COVID forced the cancellation of most elective surgeries, and now, that diminished need for surgical pain relief products has forced Sun Pharma of India to reduce its number of contracted poppy growers in Tasmania and to eliminate two of its field officers...READ MORE
- McKinsey Settles for Nearly $600 Million Over Role in Opioid Crisis (nytimes.com)
McKinsey & Company, the consultant to blue-chip corporations and governments around the world, has agreed to pay nearly $600 million to settle investigations into its role in helping “turbocharge” opioid sales, a rare instance of it being held publicly accountable for its work with clients...The firm has reached a $573 million agreement with attorneys general in 47 states, the District of Columbia and five territories, according to a court filing in Massachusetts on Thursday. Separate deals were announced in Washington State, for $13 million, and in West Virginia, for $10 million...The settlements come after lawsuits unearthed a trove of documents showing how McKinsey worked to drive sales of Purdue Pharma’s OxyContin painkiller...READ MORE
- More US citizens arrested for moving drugs over Mexico border (reviewjournal.com)
An increasing number of American citizens have been apprehended as they have tried to smuggle illegal drugs into the U.S. since the start of the coronavirus pandemic, an uptick that’s come amid travel restrictions at the border with Mexico...the closure of the southern border to nonessential traffic has sharply limited the number of foreign citizens entering the U.S. by land...Law enforcement officials and drug trafficking experts say the border rules — put in place in April 2020 to curb the spread of the coronavirus — and their lopsided enforcement are driving the rise in U.S. citizens involved in borderland drug busts...U.S. citizens were apprehended nearly seven times more often than Mexican citizens between October 2020 and March 31 for trying to smuggle drugs in vehicles, U.S. Customs and Border Protection data shows...READ MORE
- Lawmakers seek greater oversight of billions in opioid settlement funds projected for the state (thenevadaindependent.com)
A few state lawmakers are hoping to establish greater legislative oversight over how the state spends billions of dollars in opioid settlement funds projected to be won by the attorney general in litigation throughout the next decade...SB390, a bill presented by Sen. Julia Ratti (D-Sparks) and sponsored by the Senate Health and Human Services Committee, would create a state fund to house proceeds from opioid settlements, such as the $45 million Nevada is set to receive from the settlement of a lawsuit against consulting firm McKinsey & Company, which provided services for opioid manufacturers...READ MORE
- Senate committee advances bill to create ‘988’ mental health hotline, set plan for allocating opioid settlement funds (thenevadaindependent.com)
A legislative committee unanimously passed a bill that would create a state fund to house proceeds from opioid settlements, such as those against prominent pharmaceutical companies accused of helping fuel the opioid crisis...The bill would establish the “Nevada Fund for Healthy Communities,” which would hold the proceeds of state litigation against opioid manufacturers, distributors, sellers and marketers — including the $45 million Nevada is set to receive from the settlement of a lawsuit against consulting firm McKinsey & Company, which provided services for opioid manufacturers...READ MORE
- 5 Frequently Asked Questions about Drug Diversion Management (drugtopics.com)
In reality, nearly half (44%) of hospital pharmacists experienced a diversion event within the past 12 months, which is up from 37% in 2019. The COVID-19 pandemic has exacerbated this “hidden epidemic,” a multi-faceted challenge which poses serious risks to patients, clinicians and healthcare systems...Here are 5 questions frequently asked by health systems seeking to accelerate and improve their efforts to detect and mitigate drug diversion incidents...READ MORE
- What are the biggest challenges in identifying drug diversion?
- How have responsibilities for addressing and resolving drug diversion issues evolved?
- What offers the biggest opportunity to improve diversion identification?
- When selecting automated systems and software, which capabilities are most critical?
- How do you justify the cost of technology in a difficult economic environment?
- Indivior ponies up $300M to put Suboxone marketing allegations to bed (fiercepharma.com)
In 2020, Indivior resolved the federal government's long-running probe into its aggressive marketing of the opioid addiction therapy Suboxone, reaching a $600 million plea deal. Now, it's paying up...Indivior will shell out $300 million to all 50 states, the District of Columbia and Puerto Rico to resolve claims that it “falsely and aggressively” marketed its opioid addiction drug Suboxone, leading to misuse of state Medicaid funds, California Attorney General Rob Bonta...READ MORE
- Nevada announces $45M settlement with McKinsey over opioids (apnews.com)Nevada secures $45 million settlement in opioid litigation, accusing consulting firm of deceptive marketing practices that led to overdose deaths (thenevadaindependent.com)
Nevada has struck a $45 million settlement deal with McKinsey & Company for the global consulting firm’s role in advising opioid makers how to sell more prescription painkillers amid a national overdose crisis...The western state reached the deal after sitting out a multi-state settlement with McKinsey announced in February. The hard bargaining has allowed Nevada to win a settlement that’s three and a half times larger than the average settlement with other states...READ MORE